FASN and cancer: These findings indicate that ZDHHC21 acts as a tumor suppressor to inhibit malignant progression of DLBCL by facilitating FASN palmitoylation, suggesting that aberrant expression of ZDHHC21 differs in different types of cancer and that the specific biological function of ZDHHC21 may be context-dependent.